News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Moy Bracken: Unlocking Affordability and Access with HEOR
Moy Bracken/LinkedIn
Apr 14, 2025, 08:10

Moy Bracken: Unlocking Affordability and Access with HEOR

Moy Bracken, Research Unit Manager at Access to Medicine Foundation, shared a post on LinkedIn:

“Recently I was interviewed by ISPOR—The Professional Society for Health Economics and Outcomes Research for their feature article “Unlocking Affordability and Access with HEOR”.

The urgency to shape health policy with evidence has never been greater. In the interview I spoke about how HEOR serves as a critical tool in addressing health equity and how pharmaceutical companies can contribute to reducing health disparities in LMICs through sustainable strategies that create real-world impact.

You can read the article here.”

cancer HEOR ISPOR Moy Bracken OncoDaily Oncology
Special Coverage
Insight
Apr 15, 2025, 08:45
Guillermo Chantada Opens the Forum on Essential Medicines for Children with Cancer
Blog
Apr 15, 2025, 08:23
Stephen V Liu: Taletrectinib and zidesamtinib promise to move the field of ROS1 NSCLC by addressing resistance and safety
Positive
Apr 15, 2025, 08:03
Rawan Hammad: Thank you to the speakers, moderators, organizers and attendees who made SIOP Asia Riyadh 2025 a success!
Blog
Apr 15, 2025, 07:52
Basel Refky: Presenting in Lebanon, Masterclass in Cairo, and a Publication — A Tough Weekend but Fruitful
Blog
Apr 15, 2025, 07:52
Luchuo Engelbert Bain: The Future is bright - African medical students taking their future into their hands
Blog
Apr 15, 2025, 07:40
Estela Rodriguez: The second-line options for EGFR lung cancer beyond platinum-chemo after best therapies upfront
Blog
Apr 15, 2025, 07:23
EACR about their affiliated journal, Molecular Oncology
Blog
Apr 15, 2025, 07:21
Enrolling for the ComboMATCH Treatment Trial E5 - ECOG-ACRIN Cancer Research Group
Opinion
Apr 15, 2025, 07:10
The NCCN 2025 Breast Cancer Congress recorded presentations are now available
Blog
Apr 15, 2025, 07:09
Roberto Ferrara: Neoadjuvant versus perioperative chemo-immunotherapy according to pathological response in resectable NSCLC
Blog
Apr 15, 2025, 07:04
Imane Bensalim: Honored to have participated in Sim Africa 2025
Blog
Apr 15, 2025, 06:40
The application for the 2025 Ambassador Program is open - American Society of Hematology